Vienna, Austria

ESTRO 2023

Session Item

Tuesday
May 16
09:15 - 10:30
Lehar 1-3
Radiotherapy and oligometastatic prostate cancer - This house believes we are ready for a new treatment paradigm
Alfonso Gómez-Iturriaga, Spain;
Almudena Zapatero, Spain
4090
Debate
Clinical
09:18 - 09:33
For the motion
Alison Tree, United Kingdom
SP-1006

Abstract

For the motion
Authors:

Alison Tree1

1Royal Marsden NHS Foundation Trust, Urology, Sutton, Surrey, United Kingdom

Show Affiliations
Abstract Text

We will present the wealth of data suggesting better outcomes after SBRT in the treatment of metastatic disease, including biological, observational and randomised data. We will explain why it is good for the radiotherapy community to embrace change and be ready to move the field forward.